Vyxeos 44 MG / 100 MG Liposome Injection

RxCUI: 1942748
RxNorm name: Vyxeos 44 MG / 100 MG Liposome Injection
Display name: Vyxeos 44 MG / 100 MG Liposome Injection
Full name: Vyxeos 44 MG / 100 MG Liposome Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
VYXEOS	(DAUNORUBICIN AND CYTARABINE) LIPOSOME	Jazz Pharmaceuticals, Inc.	7ea701ce-e7d3-4349-a9c2-642a501d45c8	2026-01-30	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1942748

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
7ea701ce-e7d3-4349-a9c2-642a501d45c8	Vyxeos 44 MG / 100 MG Liposome Injection [PSN] · cytarabine liposome 100 MG / daunorubicin liposomal 44 MG Injection [Vyxeos] [SBD] · ara-C liposome 100 MG / Daunorubicin Liposomal 44 MG Injection [Vyxeos] [SY] · Vyxeos 44 MG / 100 MG Liposome Injection [SY]	4	14	These highlights do not include all the information needed to use VYXEOS safely and effectively. See full prescribing information for VYXEOS. VYXEOS ® (daunorubicin and cytarabine) liposome for injection, for intravenous use Initial U.S. Approval: 2017	20260130